about
Update on the management of pancreatic cancer: surgery is not enoughA bioengineered heterotypic stroma-cancer microenvironment model to study pancreatic ductal adenocarcinoma.Enhanced laser thermal ablation for the in vitro treatment of liver cancer by specific delivery of multiwalled carbon nanotubes functionalized with human serum albuminCo-delivery of cisplatin and rapamycin for enhanced anticancer therapy through synergistic effects and microenvironment modulation.Longitudinal measurement of extracellular matrix rigidity in 3D tumor models using particle-tracking microrheology.Selective ex-vivo photothermal ablation of human pancreatic cancer with albumin functionalized multiwalled carbon nanotubesVerteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines.α-Smooth muscle actin expression and desmoplastic stromal reaction in pancreatic cancer: results from the CONKO-001 study.The use of genomic information to optimize cancer chemotherapyCholangiocarcinoma: molecular pathways and therapeutic opportunitiesPlasma Shh levels reduced in pancreatic cancer patientsMolecular targeted approaches for treatment of pancreatic cancer.Aberrant glycogen synthase kinase 3β in the development of pancreatic cancer.Stromal interactions as regulators of tumor growth and therapeutic response: A potential target for photodynamic therapy?Porous silicon nanocarriers for dual targeting tumor associated endothelial cells and macrophages in stroma of orthotopic human pancreatic cancers.Nab-paclitaxel monotherapy in refractory pancreatic adenocarcinoma.The FAK scaffold inhibitor C4 disrupts FAK-VEGFR-3 signaling and inhibits pancreatic cancer growth.Hedgehog signaling and therapeutics in pancreatic cancer.Emerging pathways and future targets for the molecular therapy of pancreatic cancer.Stromal expression of SPARC in pancreatic adenocarcinoma.Desmoplastic stroma and cholangiocarcinoma: clinical implications and therapeutic targeting.Molecular Pathogenesis and Targeted Therapy of Pancreatic Cancer.Cancer-associated fibroblasts in pancreatic adenocarcinoma.Neutralizing murine TGFβR2 promotes a differentiated tumor cell phenotype and inhibits pancreatic cancer metastasis.Matricellular proteins osteopontin and osteonectin/SPARC in pancreatic carcinoma.Collagen I fiber density increases in lymph node positive breast cancers: pilot study.Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directionsStellate cells, a point of light in the dark night of pancreatic cancer.Comprehensive genomic meta-analysis identifies intra-tumoural stroma as a predictor of survival in patients with gastric cancer.The prognostic significance of cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.The Extracellular Matrix and Pancreatic Cancer: A Complex Relationship
P2860
Q28087060-D241FCC4-8E09-44C0-A80B-56B7C1BFF94AQ30557486-26A72C2E-A101-4860-BB0F-28A566560602Q30997634-139193FC-F878-4EDA-AF17-4D2C899064A9Q33716011-4F1892B2-914C-43C6-ACF9-1661D99665ACQ33872423-2641EA4F-E855-4D29-8DDF-17FF7F583ABFQ33947931-30B5D89F-88DA-49C1-ADDE-1083B79DB514Q34068126-A593D3CE-FF3B-4F32-99ED-4292DD976119Q34499655-2DE9C85D-2773-40C5-8CB5-733D922D1DA9Q34791981-D00A9BF7-FC97-4F10-8A6B-38A8FFEAD3FFQ34959174-CA9F4192-AE6D-4245-9D18-8D11E83B0737Q36113636-36447DD9-8366-4848-B51A-02950FEEF39FQ36174910-1FE27C9E-8CFA-4333-968A-45384DCEEC10Q36450022-83B0DA5E-3DBC-4F86-81D6-7A7132DC3E02Q36641872-A7B392DB-C400-4B36-82E0-611587B01AC4Q37187922-255DAACD-0DF5-4027-AC89-9DB027581CE1Q37285948-EEC8373F-CAA6-4DB8-AE4B-0495E298D669Q37381588-9BD18DE2-91FF-4A81-B9A4-C8346ABD084CQ37824127-8E603BB3-DC24-428D-8EFB-9FF0879A7875Q37912219-93660971-8908-4120-B6CA-637395861543Q38108253-D4D809A9-F414-401E-A7D1-F5DC94C1BEFBQ38152382-2FD6C116-4B49-4FFB-9E4F-BBE0517C5D5EQ38370174-44DFF7FE-92F6-4FAE-8B43-E467FEB63A2AQ38568893-95C802C5-E3D6-4EF4-8EFB-CA544A4910A9Q38971921-D7F33ED9-9C54-422E-A9B3-D536B5AD00B1Q39588669-EFCDF97F-B6B5-4E79-BFC0-20F98A751B65Q41579374-E2A227E5-826E-47FA-AF9D-5645C47D91A1Q41608480-08B87832-64D3-45FB-8FA0-DE319E4F9CCDQ42947958-1F1EEEFF-063F-4896-A803-17B91B7F3A3AQ46898080-6B51CCAF-FDBF-4E61-AC59-8A7072B9DB0AQ47660903-21E6CCCD-6342-461C-AEF0-F0A0804387D2Q57159994-933E65D4-EEE9-484F-93B2-A177871FDFF4
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Stromal depletion goes on trial in pancreatic cancer.
@en
Stromal depletion goes on trial in pancreatic cancer.
@nl
type
label
Stromal depletion goes on trial in pancreatic cancer.
@en
Stromal depletion goes on trial in pancreatic cancer.
@nl
prefLabel
Stromal depletion goes on trial in pancreatic cancer.
@en
Stromal depletion goes on trial in pancreatic cancer.
@nl
P356
P1476
Stromal depletion goes on trial in pancreatic cancer.
@en
P2093
Ken Garber
P304
P356
10.1093/JNCI/DJQ113
P407
P577
2010-03-25T00:00:00Z